Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets

Datum: 20. Januar 2025Zeit: 13:00 – 14:00Ort: Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid

Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets

Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals GmbH & Co. KG, Martinsried

Time: Monday, January 20, 2025; 13:00h

Location: Seminarraum Physiologie VKL 4.1.29 Universität Regensburg and Zoom

To get the Zoom link please contact: michaela.kritzenberger@ur.de

Zum Kalender hinzufügen

Details

Datum:
20. Januar 2025
Zeit:
13:00 – 14:00
Ort:

Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid

Veranstaltungskategorien:
Gastsprecherseminar